drugset / Trial / NCT00020358

Vaccine Therapy in Treating Patients With Melanoma

NCT00020358

RandomizedTreatment

Summary

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. Vaccine therapy may be an effective treatment for melanoma. PURPOSE: Randomized phase II trial to study the effectiveness of three vaccine therapy regimens in treating patients who have melanoma.

Timeline

Start
2000-09
Primary completion
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject aldesleukin Protein / enzyme biologic Intravenous
Subject gp100 antigen Peptide Subcutaneous
Subject tyrosinase peptide Peptide Subcutaneous
Background incomplete Freund's adjuvant Other / unclassified

Indications